Yuji U. Miura
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 119 publications
Complete response to immune checkpoint blockade in sarcomatoid renal cell carcinoma with bone marrow metastasis: case report with tumor immune microenvironment profiling.
Journal: Journal for immunotherapy of cancer
Published: May 11, 2026
Circulatory compromise as a potential mechanism of fatal hepatic failure during long-term selpercatinib therapy: pharmacokinetic and clinical insights.
Journal: Cancer chemotherapy and pharmacology
Published: May 06, 2026
Real-World Outcomes of Olaparib Treatment in Japanese Patients With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA Pathogenic or Likely Pathogenic Variants.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: April 03, 2026
Bayesian interpretation of febrile neutropenia risk and primary granulocyte colony-stimulating factor prophylaxis during darolutamide triplet therapy.
Journal: Japanese journal of clinical oncology
Published: February 22, 2026
Real-world insights from comprehensive genomic profiling in patients with metastatic castration-resistant prostate cancer.
Journal: Japanese journal of clinical oncology
Published: January 22, 2026
Continuous administration of lenvatinib after first documented disease progression in patients with radioiodine-refractory thyroid cancer.
Journal: Endocrine
Published: December 25, 2025
Evaluation of Exercise Tolerance in Cancer Patients With Cardiovascular Complications: A Japanese Single-Center Retrospective Study Using Cardiopulmonary Exercise Testing.
Journal: Circulation reports
Published: December 21, 2025
Sex differences in chemotherapy-induced alopecia distress using the Japanese version of the Chemotherapy-Induced Alopecia Distress Scale.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: December 18, 2025
Real-world platinum selection in immune checkpoint inhibitor-based therapy for recurrent or metastatic head and neck cancer: an exploratory multi-institutional retrospective study.
Journal: Scientific reports
Published: October 30, 2025
Effect of organism aging on the development of anti-PD-(L)1 therapy-associated adverse events.
Journal: Immunological medicine
Published: October 01, 2025
A Case of Combined Small-cell Carcinoma and Adenocarcinoma of the Lung With EGFR Exon 19 Deletion Identified via Liquid Genomic Profiling.
Journal: In vivo (Athens, Greece)
Published: June 23, 2025
Last Updated: 09/26/2026